Furthermore, patients with severe refractory LN, for example, those with lower albumin levels (less than 35 g/L) and lower eGFR (less than 90 mL/min/1.73 m2) at 12 months, appeared to benefit more from the therapeutic effects of LEF. Here, ALB is linked to lobular neoplasia.